Creatinine Quantitative Testing Drug
Vietnam·Risk Class TTBYT Loại B·CREP2·Roche Diagnostics (Suzhou) Ltd.·Registered Mar 04, 2024- Analysis ID
- 240000442/PCBB-HCM
- Submission ID
- 000.00.19.H29-240228-0028
- Product Type
- CREP2
- Product Code
- 05168589214
- Manufacturer
- Roche Diagnostics (Suzhou) Ltd.
- Authorized Representative
- CÔNG TY TNHH ROCHE VIỆT NAM
- Intended Use
- In vitro testing used to quantify creatinine in human serum, plasma, and urine on various Roche/Hitachi cobas systems.
- Registration Date
- Mar 04, 2024
Companies providing products similar to "Creatinine Quantitative Testing Drug"
Recently registered similar products
Access comprehensive regulatory information for Creatinine Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240000442/PCBB-HCM and manufactured by Roche Diagnostics (Suzhou) Ltd.. The authorized representative in Vietnam is CÔNG TY TNHH ROCHE VIỆT NAM.
This page provides complete technical specifications, regulatory compliance details, 3 companies making similar products including Abbott Ireland Diagnostics Division, Ortho-Clinical Diagnostics Inc., and 4 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.